Recent Posts

1. 

   Sotyktu floundering

   If the product was great then it would be producing great revenues. Fact is the dermatology prescribers don't like Sotyktu. Most will tell you it's the side effect profile. It's too similar to a JAK. You can't overcome product labeling. BMY...

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 10:59 AM

2. 

   Shortages and outages for Mounjaro and Zepbound

   Exactly! How long before announcement on sales force restructuring? Early buyout for those over 50? Joining pc1/2 and spec rep territories?

   Eli Lilly

   anonymous

   Apr 26, 2024 at 10:56 AM

3. 

   The final countdown…

   I would be very careful about staying onboard this sinking ship just the same.

   Alkermes

   anonymous

   Apr 26, 2024 at 10:48 AM

4. 

   401k Defined Contribution 27% Haircut

   Interesting way to pay for the NSM

   Astellas

   anonymous

   Apr 26, 2024 at 10:48 AM

5. 

   Scilex a Good company to get into?

   Its alright. Been in Pharma for a while with over 8 different companies big and small. The most important thing in my career has been the manager. The other insanity that goes on with this company is laughable, frustrating and fun with the...

   Scilex Pharmaceuticals

   anonymous

   Apr 26, 2024 at 10:48 AM

6. 

   Worst DM

   Here's to Paula Russell being the first manager cut!

   Astellas

   anonymous

   Apr 26, 2024 at 10:43 AM

7. 

   Vaccines reorg?

   Joaquin sure has a lot of work experiences. Whether than translates to success in his current position is to soon to tell. I'd rather have his at the helm rather than someone with less experience.

   GlaxoSmithKline

   anonymous

   Apr 26, 2024 at 10:43 AM

8. + Show More